Plunkett Research Online: MediGene AG

MEDIGENE AG (MDGEF) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and O.....


MEDIGENE AG

Ticker: MDGEF
Exchange: OTCM
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 49 898565290
Fax: 49 8985652920
Address:
Planegg-Martinsried, D-82152

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and O.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture